drugset / Trial / NCT07500805
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
Phase 1
Not yet recruiting
21 enrolled
UTC Therapeutics Inc.
The First Affiliated Hospital of Zhengzhou University · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of UCL70805F in patients with CD70-positive advanced renal clear cell carcinoma.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2028-05-01
- Completion
- 2029-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCL70805F | Unknown | 50000 cells | Intravenous |
| Subject | UCL70805F | Unknown | 400000 cells | Intravenous |